114 related articles for article (PubMed ID: 1796916)
1. Cardiovascular effects of the new dihydropyridine derivative elgodipine.
Tamargo J; López-Sendón J; Delpón E; González-Morales M; de Miguel E
Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of oxodipine and nifedipine in the isolated guinea-pig heart.
Tejerina T; Delgado C; Valenzuela C; Tamargo J
Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):186-99. PubMed ID: 3675081
[TBL] [Abstract][Full Text] [Related]
3. TMB-8 as a pharmacologic tool in guinea pig myocardial tissues. I. Effects of TMB-8 on force of contraction and on action potential parameters in atrial and papillary muscles.
Himmel HM; Ravens U
J Pharmacol Exp Ther; 1990 Oct; 255(1):293-9. PubMed ID: 1698970
[TBL] [Abstract][Full Text] [Related]
4. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
5. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
Nakaya H; Hattori Y; Nakao Y; Kanno M
Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
Drieu la Rochelle CD; Grosset A; O'Connor SE
Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
[TBL] [Abstract][Full Text] [Related]
7. Inotropic and electrophysiological effects of PY 108-068 on isolated cardiac preparations.
Tejerina MT; Delgado C; Diez J; Tamargo J
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):64-80. PubMed ID: 6497511
[TBL] [Abstract][Full Text] [Related]
8. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
Sassen LM; Soei LK; Koning MM; Verdouw PD
Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
[TBL] [Abstract][Full Text] [Related]
9. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
[TBL] [Abstract][Full Text] [Related]
10. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
11. [Effects of 3,6-dimethamidodibenzopyriodonium citrate (I-65) on action potentials and contractions in guinea pig papillary muscles].
Cui Y; Tan YH
Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):126-30. PubMed ID: 2816412
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
[TBL] [Abstract][Full Text] [Related]
18. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular profile of oxodipine, a novel dihydropyridine calcium channel blocker, in anesthetized open-chest dogs: a comparison with nitrendipine.
Alloui A; Talmant JM; Duchêne-Marullaz P
Arch Int Pharmacodyn Ther; 1991; 313():63-75. PubMed ID: 1816765
[TBL] [Abstract][Full Text] [Related]
20. LY249933: a cardioselective 1,4-dihydropyridine with positive inotropic activity.
Holland DR; Wikel JH; Kauffman RF; Smallwood JK; Zimmerman KM; Utterback BG; Turk JA; Steinberg MI
J Cardiovasc Pharmacol; 1989 Sep; 14(3):483-91. PubMed ID: 2476630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
